Insider trade

HRT FINANCIAL LP, 10% owner at Shuttle Pharmaceuticals Holdings, bought ~$28K of Shuttle Pharmaceuticals Holdings shares.

~$28K
Approx. value · 7,851 sh @ $3.54
90K
Holds after · shares reported
Traded
Jul 2, 2026
Filed
Jul 7, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 1, 2026Company filing · Form 8-K · Material agreement, Acquisition or saleCompleted buying or selling a business or assets, and changed a top executive or board member (and 4 more items)“On May 4, 2026, in connection with the consummation of the Merger and pursuant to the Merger Agreement, the Board of Directors of Shuttle approved the appointment of Ryan Trasolini, Chief Executive Officer of the Company, as Co-Chief Executive Officer of the Acquiror, effective at the Effective Time.”
  2. May 1, 2026Company filing · Form 8-K · Acquisition or saleCompleted buying or selling a business or assets
  3. Jun 10, 2026Company filing · Form 8-K · Shareholder rights, Bylaws or charterChanged the rights of its shareholders, and changed its bylaws, charter or fiscal year
  4. Jun 29, 2026Insider · First insider buy on record10% owner purchased ~$89K of SHPH shares in the open market
  5. Jun 30, 2026Insider10% owner purchased ~$22K of SHPH shares in the open market
  6. Jul 1, 2026Insider10% owner purchased ~$13K of SHPH shares in the open market
  7. Jul 2, 2026 · this disclosureInsider10% owner purchased ~$28K of SHPH shares in the open market

What came next

  1. Jul 6, 2026Insider10% owner sold ~$32K of SHPH shares in the open market
  2. Jul 7, 2026Insider10% owner sold ~$35K of SHPH shares in the open market
  3. Jul 8, 2026Insider10% owner sold ~$65K of SHPH shares in the open market
  4. Jul 9, 2026Insider10% owner purchased ~$28K of SHPH shares in the open market
  5. Jul 10, 2026Insider10% owner purchased ~$2.3K of SHPH shares in the open market
  6. Jul 13, 2026Insider10% owner sold ~$4.8K of SHPH shares in the open market
  7. Jul 14, 2026Insider10% owner sold ~$368K of SHPH shares in the open market
  8. Aug 28, 2026Company filing · Form 8-K · Listing notice, Reg FDReceived a notice from its stock exchange, and shared information with investors“On August 28, 2026, Shuttle Pharmaceuticals Holdings, Inc. (the “Company”) received a notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the Company’s delay in filing its Quarterly Report on Form 10-Q for the period ended June 30, 2026 (the “Form 10-Q”) with the Securities and Exchange Commission (the “SEC”), the…”
  9. Aug 31, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
  10. Sep 9, 2026Company filing · Form 8-K · Unregistered sharesSold new shares without registering them
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Shuttle Pharmaceuticals Holdings

For Shuttle Pharmaceuticals Holdings, OQRO holds 4 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SHPH page.

Other recent filings by HRT FINANCIAL LP, 10% owner

The full history of HRT FINANCIAL LP, 10% owner is on the profile page.

How this filing works

Other disclosures at Shuttle Pharmaceuticals Holdings

Everything OQRO holds on this company is on its SHPH page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data